Results 241 to 250 of about 25,935 (265)

Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1

Nature Cancer, 2022
Nathaniel W Mabe, Gabriela Alexe, Julia A Belk   +2 more
exaly  

Gd2(MoO4)3-Gd2(WO4)3, 17B-14

2006
M. Adachi, Y. Akishige, T. Asahi, K. Deguchi, K. Gesi, K. Hasebe, T. Hikita, T. Ikeda, Y. Iwata, M. Komukae, T. Mitsui, E. Nakamura, N. Nakatani, M. Okuyama, T. Osaka, A. Sakai, E. Sawaguchi, Y. Shiozaki, T. Takenaka, K. Toyoda, T. Tsukamoto, T. Yagi   +21 more
openaire   +1 more source

MPEC 2024-G125 : 2024 GD2

The Minor Planet Electronic Circulars contain information on unusual minor planets, routine data on comets and natural satellites, and occasional editorial announcements. They are published on behalf of Division F of the International Astronomical Union by the Minor Planet Center, Smithsonian Astrophysical Observatory, Cambridge, MA 02138, U.S.A.
openaire   +1 more source

Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma

Molecular Cancer, 2023
Dinglan Wu
exaly  

Gd2/3Cr2S4

2003
W. Suski, T. Palewski
openaire   +1 more source

A facile total synthesis of ganglioside GD2

Carbohydrate Research, 1994
H, Ishida, Y, Ohta, Y, Tsukada, Y, Isogai, H, Ishida, M, Kiso, A, Hasegawa   +6 more
openaire   +2 more sources

Anti-GD2 CAR-NKT cells in relapsed or refractory neuroblastoma: updated phase 1 trial interim results

Nature Medicine, 2023
Andras A Heczey, Xin Xu, Amy N Courtney
exaly  

GD2 Binding

2020
openaire   +1 more source

GD2-KLH Vaccine

2020
openaire   +1 more source

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

New England Journal of Medicine, 2010
Wendy Beth London, Malcolm A Smith, Judith G Villablanca   +2 more
exaly